EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Best Medical Stocks To Research - January 18th - Markets Daily
AstraZeneca PLC $AZN Shares Sold by QRG Capital Management Inc.
AstraZeneca PLC (NASDAQ:AZN) Short Interest Update - Daily Political
AstraZeneca PLC $AZN Shares Sold by Sumitomo Mitsui Trust Group Inc. - Stock Observer
Top Medical Stocks Worth Watching - January 17th - Markets Daily
Merck's Oncology Deals And Genomics Push Might Change The Case For Investing In Merck (MRK)
Klein Pavlis & Peasley Financial Inc. Makes New $1.08 Million Investment in AstraZeneca PLC $AZN - Stock Observer
AstraZeneca (NASDAQ:AZN) Downgraded to "Buy" Rating by Wall Street Zen
Shore Capital Sticks to Its Buy Rating for AstraZeneca (AZN) | Markets Insider
12 Best Future Stocks to Buy For the Long Term
Pharmaceutical Stocks To Keep An Eye On - January 16th - Markets Daily
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for AstraZeneca (LON:AZN) Stock Price - Markets Daily
AstraZeneca (LON:AZN) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says
AstraZeneca (LON:AZN) Receives Buy Rating from Shore Capital - Daily Political
Barclays Sticks to Its Buy Rating for AstraZeneca (AZN) | Markets Insider
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland
What Makes AstraZeneca (AZN) a Strong Growing Company?
AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference
Rep. Julia Letlow Buys AstraZeneca PLC (NASDAQ:AZN) Shares
AstraZeneca (NASDAQ:AZN) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.
TR/CC CRB Index (TRCCRB) - Investing.com Canada
Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences | Morningstar
Manning & Napier Advisors LLC Sells 390,342 Shares of AstraZeneca PLC $AZN - Stock Observer
Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples
Promising Pharmaceutical Stocks To Add to Your Watchlist - January 13th - Markets Daily
Illumina launches dataset to speed up AI-powered drug discovery - The Economic Times
AstraZeneca to acquire Modella AI to speed oncology drug research
ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial
Is Walmart now a tech company? Stock surges after AI moves, Nasdaq-100 inclusion. | Morningstar
SG Americas Securities LLC Grows Stock Position in AstraZeneca PLC $AZN
Assessing Walmart (WMT) Valuation As Nasdaq 100 Entry And Tech Push Draw Fresh Attention
Artificial intelligence agents in cancer research and oncology
AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit
Nasdaq Adds Walmart To Nasdaq-100, Drops AstraZeneca In Index Reshuffle | Crowdfund Insider
Nasdaq-100 reshuffle: Walmart set to join US stock market index; to replace AstraZeneca from January 20 - The Times of India
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) - Here's Why
Walmart to join Nasdaq 100 from January 20 as AstraZeneca exits the index
Walmart Joins Nasdaq-100, Replacing AstraZeneca: Key Corporate Shift, ETRetail
Walmart to join Nasdaq 100 on Jan 20 as AstraZeneca exits - The Business Times
Walmart to replace AstraZeneca on Nasdaq-100 Index on January 20
Oak Family Advisors LLC Sells 23,242 Shares of AstraZeneca PLC $AZN
European Drug Pricing Tensions Rise After Trump's U.S. Price Cuts, ETPharma
Cellectis Announces 2026 Strategy and Catalysts
Cellectis annonce sa stratégie et ses jalons attendus en 2026
AstraZeneca's (AZN) Overweight Rating Reaffirmed at JPMorgan Chase & Co. - Markets Daily
JPMorgan Chase & Co. Reiterates Overweight Rating for AstraZeneca (LON:AZN)
Park Avenue Securities LLC Boosts Stock Position in AstraZeneca PLC $AZN
Vaughan Nelson Investment Management L.P. Acquires Shares of 23,726 AstraZeneca PLC $AZN - Markets Daily
Vaughan Nelson Investment Management L.P. Makes New Investment in AstraZeneca PLC $AZN - Daily Political
Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 35% One-Year Rally?
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis
AstraZeneca (LON:AZN) Sets New 52-Week High - Still a Buy?
AstraZeneca (LON:AZN) Stock Crosses Above 200-Day Moving Average - Should You Sell?
European Shares Seen Mostly Higher In Cautious Trade
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study
)
Quality quartet sprinkle more gold dust on glittering Awards sponsor line-up
Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis
AstraZeneca (NASDAQ:AZN) Sets New 1-Year High - What's Next?
AZN: Oncology And Biopharma Execution Will Offset Patent Pressure Concerns
Is China's ENHERTU Approval in HR-positive HER2-low Breast Cancer Altering The Investment Case For Daiichi Sankyo Company (TSE:4568)?
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study
AstraZeneca PLC $AZN Stake Boosted by Allspring Global Investments Holdings LLC
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Taking Stock of AstraZeneca (LSE:AZN): Is Its 31% One-Year Return Now Fully Valued?
AstraZeneca (NASDAQ:AZN) Upgraded to Strong-Buy at Wall Street Zen
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Q4 EPS Estimates for AstraZeneca Boosted by Zacks Research
Optimizing cardiovascular pharmacotherapy in older adults with frailty
My Personal CFO LLC Acquires Shares of 38,411 AstraZeneca PLC $AZN
I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…
Zacks Research Raises Earnings Estimates for AstraZeneca - Stock Observer
25,322 Shares in AstraZeneca PLC $AZN Purchased by Moody Lynn & Lieberson LLC
Smith Salley Wealth Management Raises Stock Holdings in AstraZeneca PLC $AZN
Ethic Inc. Acquires 11,638 Shares of AstraZeneca PLC $AZN
Regulatory actions for Dec. 30, 2025 | BioWorld
DAVENPORT & Co LLC Increases Stake in AstraZeneca PLC $AZN
China's rising biotech clout on show in flurry of billion-dollar licensing deals | South China Morning Post
Robbins Farley Purchases 27,582 Shares of AstraZeneca PLC $AZN
Jacobio, AstraZeneca ink cancer drug deal - Chinadaily.com.cn
Insider Selling: AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock - Stock Observer
AstraZeneca Reaches Settlement With MSN Labs Over Cancer Drug
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications
